These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 37608502

  • 1. Fiber-Specific White Matter Alterations in Parkinson's Disease Patients with GBA Gene Mutations.
    Andica C, Kamagata K, Uchida W, Saito Y, Takabayashi K, Hagiwara A, Takeshige-Amano H, Hatano T, Hattori N, Aoki S.
    Mov Disord; 2023 Nov; 38(11):2019-2030. PubMed ID: 37608502
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls.
    den Heijer JM, Cullen VC, Pereira DR, Yavuz Y, de Kam ML, Grievink HW, Moerland M, Leymarie N, Khatri K, Sollomoni I, Spitalny L, Dungeon L, Hilt DC, Justman C, Lansbury P, Groeneveld GJ.
    Mov Disord; 2023 May; 38(5):783-795. PubMed ID: 36916660
    [Abstract] [Full Text] [Related]

  • 5. Neuroimaging in Glucocerebrosidase-Associated Parkinsonism: A Systematic Review.
    Filippi M, Balestrino R, Basaia S, Agosta F.
    Mov Disord; 2022 Jul; 37(7):1375-1393. PubMed ID: 35521899
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA Mutations.
    Caminiti SP, Carli G, Avenali M, Blandini F, Perani D.
    Mov Disord; 2022 Jan; 37(1):106-118. PubMed ID: 34596920
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations.
    De Michele G, Palmieri GR, Pane C, Valente EM, Palmieri I, Dello Iacovo CDP, Cuomo N, Giglio A, De Lucia N, Fico T, Perillo S, De Michele G, De Rosa A.
    Acta Neurol Belg; 2023 Feb; 123(1):221-226. PubMed ID: 36609835
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Probing bundle-wise abnormalities in patients infected with human immunodeficiency virus using fixel-based analysis: new insights into neurocognitive impairments.
    Zhao J, Jing B, Liu J, Chen F, Wu Y, Li H.
    Chin Med J (Engl); 2023 Sep 20; 136(18):2178-2186. PubMed ID: 37605986
    [Abstract] [Full Text] [Related]

  • 16. Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson's Disease.
    Zarkali A, McColgan P, Leyland LA, Lees AJ, Weil RS.
    Mov Disord; 2021 May 20; 36(5):1191-1202. PubMed ID: 33421201
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene.
    Thaler A, Bregman N, Gurevich T, Shiner T, Dror Y, Zmira O, Gan-Or Z, Bar-Shira A, Gana-Weisz M, Orr-Urtreger A, Giladi N, Mirelman A.
    Parkinsonism Relat Disord; 2018 Oct 20; 55():45-49. PubMed ID: 29784561
    [Abstract] [Full Text] [Related]

  • 19. Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
    Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Glinka T, Goldstein O, Kestenbaum M, Cedarbaum JM, Mabrouk OS, Fraser KB, Shirvan JC, Orr-Urtreger A, Mirelman A, Thaler A.
    Mov Disord; 2022 Jan 20; 37(1):190-195. PubMed ID: 34550621
    [Abstract] [Full Text] [Related]

  • 20. Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review.
    Behl T, Kaur G, Fratila O, Buhas C, Judea-Pusta CT, Negrut N, Bustea C, Bungau S.
    Transl Neurodegener; 2021 Jan 15; 10(1):4. PubMed ID: 33446243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.